Original Source(s)
Related Content
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
The Diagnosis Begins With You
This Breast Cancer Awareness Month, Michele Mitchell reflects on the invaluable role of pathology in the patient journey
October 13, 2026
-
5 min
Musings from The Power List: Ansgar Korf
Could reusable mass spectrometry data transform analytical science?
October 9, 2026
-
7 min
